파라택시스코리아

288330KOSDAQ그외 기타 전문, 과학 및 기술 서비스업

61.8 / 100

Reference Date: 2026-06-10

Financial Score20.5 / 40

News Sentiment21.3 / 25

Momentum10.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but ROE is below the industry average. Roughly flat over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Parataxis Korea operates two main business segments: digital assets and biotechnology. In the digital asset division, the company holds Bitcoin as a strategic financial asset and aims to generate revenue through mining operations. The biotechnology division focuses on developing innovative drugs for unmet medical needs, with key candidates like BBT-207 and BBT-877 currently in clinical trials for lung cancer and idiopathic pulmonary fibrosis, respectively.

Number of Employees

16people

Average Salary

74.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 48.804.0Point

PBR

1.01Industry Average 1.435.5Point

Lower than industry avg (good)

ROE

-90.37Industry Average 0.940.0Point

Well below industry avg

Debt Ratio

8.93Industry Average 12.515.0Point

Lower than industry avg (good)

Trend 2023~20256.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲107.7% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲36.6% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -97.2% (improving, 3yr)

Detailed News Sentiment

4 totalPositive 4Neutral 0Negative 0Average Sentiment Score 85

Positive
"보안사업 수익→이더리움 축적→R&D 투자…선순환구조 만들 것" [일문...
파라택시스의 이더리움 기반 보안 사업 확장으로 인해 수익 증가와 기관 신뢰 인프라 구축이 예상되며, 네이티브 스테이킹 수익률 상승으로 긍정적 전망.
Positive
파라택시스이더리움 "기관급 거버넌스로 국내 최대 DAT 플랫폼 도약"
파라택시스이더리움의 이더리움 보유량 증가와 파라택시스코리아와의 합병 추진으로 인해 기업의 시장 지위 강화와 수익성 향상 기대.
Positive
유한양행, 美길리어드와 2100억원 규모 원료의약품 공급 계약
유한양행의 대규모 API 공급 계약 체결로 인해 파라택시스코리아와 관련된 간접적인 긍정적 영향 기대.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 416Won52-week high 3,41552-week low 416

1-month return3.0Point

1m 0% (flat)

Volume trend6.0Point

Volume surge

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral기타시장안내 (개선계획서 제출)2026-06-08
Neutral주권매매거래정지기간변경 (상장적격성 실질심사 대상 결정)2026-05-21
Neutral기타시장안내 (상장적격성 실질심사 대상 결정)2026-05-21
Neutral분기보고서 (2026.03)2026-05-15